X

Trial Profile

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin lispro/pramlintide (Primary) ; Insulin lispro; Pramlintide
Indications Type 1 diabetes mellitus
Focus First in man; Pharmacokinetics
Sponsors Adocia

Most Recent Events

10 Sep 2019 According to an Adocia media release, results of this study will be presented at the upcoming 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), being held September 16-20, 2019 in Barcelona, Spain.
10 Sep 2019 Results published in the Adocia Media Release
11 Jun 2019 Safety and efficacy results presented at the 79th Annual Scientific Sessions of the American Diabetes Association.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com